Skip to main content

Peer Review reports

From: In-silico evaluation of Malawi essential medicines and reactive metabolites for potential drug-induced toxicities

Original Submission
10 Nov 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
21 Dec 2020 Reviewed Reviewer Report
26 Dec 2020 Reviewed Reviewer Report
29 Dec 2020 Reviewed Reviewer Report
18 Feb 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 5
18 Feb 2021 Submitted Manuscript version 5
20 Feb 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 6
20 Feb 2021 Submitted Manuscript version 6
22 Feb 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 7
22 Feb 2021 Submitted Manuscript version 7
23 Feb 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 8
23 Feb 2021 Submitted Manuscript version 8
23 Feb 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 9
23 Feb 2021 Submitted Manuscript version 9
2 Mar 2021 Reviewed Reviewer Report
3 Mar 2021 Reviewed Reviewer Report
15 Mar 2021 Reviewed Reviewer Report
21 Mar 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 10
21 Mar 2021 Submitted Manuscript version 10
23 Mar 2021 Reviewed Reviewer Report
23 Apr 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 11
23 Apr 2021 Submitted Manuscript version 11
29 Apr 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 12
29 Apr 2021 Submitted Manuscript version 12
5 May 2021 Author responded Author comments - Ibrahim Chikowe
Resubmission - Version 13
5 May 2021 Submitted Manuscript version 13
Publishing
10 May 2021 Editorially accepted
16 Jun 2021 Article published 10.1186/s40360-021-00499-6

You can find further information about peer review here.

Back to article page